CliffBio
small molecule

RENAGEL

SEVELAMER HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyGenzyme →See this company's full patent-cliff portfolio

Drug detail

Brand nameRENAGEL
Active ingredientSEVELAMER HYDROCHLORIDE
Strength400MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2000
Marketing statusRX

More from Genzyme

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.